PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 143-8540, Tokyo, Japan.\', \'Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 143-8540, Tokyo, Japan. Electronic address: yishii@med.toho-u.ac.jp.\', \'Fujirebio Inc., 51 Komiya-machi, Hachioji, 192-0031, Tokyo, Japan.\', \'General Medicine and Emergency Center (Internal Medicine), Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, 143-8541, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(20)30428-110.1016/j.jiac.2020.11.021
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33423918
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all